NEOSENTIA NIPD GENETICS LIQUID BIOPSY CANCER
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

NEOSENTIA NIPD GENETICS LIQUID BIOPSY CANCER Trademark

Serial Number: 79291704 • Registration: 6297681

NEOSENTIA NIPD GENETICS LIQUID BIOPSY CANCER is a trademark filed by NIPD Genetics Public Company Limited on June 8, 2020. The trademark is classified under Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

NIPD Genetics Public Company Limited (12 trademarks)

Neas Engomis 31, Engomi

Entity Type: 99

MEDICOVER PUBLIC CO LTD (17 trademarks)

31, Neas Engomis, Engomi

Entity Type: 99

Trademark Details

Filing Date

June 8, 2020

Registration Date

March 23, 2021

Published for Opposition

January 5, 2021

Goods & Services

Kits composed of reagents for genetic testing for medical and scientific research purposes; kits composed of reagents for genetic testing for medical and scientific research purposes in the field of oncology; kits composed of reagents for cancer diagnosis and prognosis for medical and scientific research purposes; kits composed of reagents for testing for chromosomal or mutational abnormalities in cancer patients for medical and scientific research purposes

Medical laboratory services for cancer testing; design and development of medical diagnostic tests and products; medical and scientific research in the field of genetic testing particularly in the field of oncology; providing medical and scientific research information in the field of genetic testing; genetic testing for scientific research and analysis purposes in the field of oncology cancer; genetic engineering services for scientific research purposes

Medical testing services for diagnosis of cancer; medical genetic testing; medical diagnostic testing in the field of oncology; medical testing of blood for diagnosis of genetic abnormalities such as mutations during cancer disease; medical testing for diagnosis of genetic disorders, diseases and syndromes; genetic testing for diagnostic or treatment purposes and genetic counseling in the field of cancer treatment; medical and healthcare services relating to DNA, genetics and genetic testing

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 23, 2026 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jan 16, 2025 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 14, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 14, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 14, 2023 REAP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 2, 2022 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Oct 29, 2022 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 23, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Sep 23, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 23, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 23, 2022 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 15, 2021 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Jun 30, 2021 XXSS
GENERIC MADRID TRANSACTION CREATED
Jun 30, 2021 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 23, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 23, 2021 R.PR
NOTIFICATION PROCESSED BY IB
Jan 11, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 5, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jan 5, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 23, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 23, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 16, 2020 NONP
ASSIGNED TO LIE
Nov 30, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 30, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 25, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 25, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 25, 2020 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 30, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 30, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 30, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 30, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 30, 2020 COAR
REFUSAL PROCESSED BY IB
Oct 19, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 1, 2020 RFCS
REFUSAL PROCESSED BY MPU
Oct 1, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 11, 2020 RFCR
NON-FINAL ACTION WRITTEN
Sep 10, 2020 CNRT
ASSIGNED TO EXAMINER
Sep 9, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 21, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 17, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 13, 2020 REPR